Statement Of Income And Retained Earnings

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7557806

Concept 2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
409,000,000 JPY
5,779,000,000 JPY
658,000,000 JPY
-6,000,000 JPY
6,181,000,000 JPY
-1,073,000,000 JPY
5,108,000,000 JPY
5,088,000,000 JPY
-16,000,000 JPY
-653,000,000 JPY
717,000,000 JPY
5,449,000,000 JPY
4,795,000,000 JPY
376,000,000 JPY
Non-operating income
Non-operating income
3,000,000 JPY
433,000,000 JPY
0 JPY
379,000,000 JPY
Non-operating expenses
Non-operating expenses
58,000,000 JPY
308,000,000 JPY
1,000,000 JPY
294,000,000 JPY
Ordinary profit (loss)
603,000,000 JPY
5,232,000,000 JPY
717,000,000 JPY
4,880,000,000 JPY
Extraordinary income
Extraordinary income
124,000,000 JPY
9,683,000,000 JPY
Extraordinary losses
Extraordinary losses
JPY
8,400,000,000 JPY
Profit (loss) before income taxes
603,000,000 JPY
5,357,000,000 JPY
717,000,000 JPY
6,163,000,000 JPY
Income taxes - current
39,000,000 JPY
1,108,000,000 JPY
61,000,000 JPY
983,000,000 JPY
Income taxes - deferred
-27,000,000 JPY
10,000,000 JPY
-27,000,000 JPY
890,000,000 JPY
Profit (loss)
591,000,000 JPY
591,000,000 JPY
591,000,000 JPY
591,000,000 JPY
4,238,000,000 JPY
682,000,000 JPY
682,000,000 JPY
682,000,000 JPY
4,290,000,000 JPY
682,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.